Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Zinzani PL, Tani M, Gabriele A, Gherlinzoni F, De Vivo A, Ricci P, Bandini G, Lemoli RM, Motta MR, Rizzi S, Guidice V, Zompatori M, Stefoni V, Alinari L, Musuraca G, Marchi E, Bassi S, Conte R, Pileri S, Tura S, Baccarani M. Zinzani PL, et al. Among authors: conte r. Leuk Lymphoma. 2004 Feb;45(2):321-6. doi: 10.1080/10428190310001597900. Leuk Lymphoma. 2004. PMID: 15101718
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Isidori A, Motta MR, Tani M, Terragna C, Zinzani P, Curti A, Rizzi S, Taioli S, Giudice V, D'Addio A, Gugliotta G, Conte R, Baccarani M, Lemoli RM. Isidori A, et al. Among authors: conte r. Biol Blood Marrow Transplant. 2007 Oct;13(10):1224-32. doi: 10.1016/j.bbmt.2007.07.004. Epub 2007 Aug 24. Biol Blood Marrow Transplant. 2007. PMID: 17889360 Free article. Clinical Trial.
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D'Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM. Curti A, et al. Among authors: conte r. Br J Haematol. 2007 Nov;139(3):415-24. doi: 10.1111/j.1365-2141.2007.06832.x. Br J Haematol. 2007. PMID: 17910631 Free article. Clinical Trial.
Hematopoietic mixed chimerism after allogenic BMT.
Manfroi S, Bontadini A, Bonifazi F, Bandini G, Conte R. Manfroi S, et al. Among authors: conte r. Transfusion. 2003 Dec;43(12):1758-9. doi: 10.1111/j.0041-1132.2003.00580.x. Transfusion. 2003. PMID: 14674373 No abstract available.
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells.
Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F, Capanni P, Polito L, Ratta M, Pileri S, Piccioli M, Basso G, Rissotto L, Conte R, Gobbi M, Stirpe F, Ferrara GB. Pistillo MP, et al. Among authors: conte r. Blood. 2003 Jan 1;101(1):202-9. doi: 10.1182/blood-2002-06-1668. Epub 2002 Aug 15. Blood. 2003. PMID: 12393538 Free article.
443 results